APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Analysis Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Peptide Analysis Services Market Analysis and Forecast 2026-2032

17 January 2026195 pages

Choose your research edition.

Industry ResearchPeptide Analysis Services Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Analysis Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Peptide Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Analysis Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Analysis Services Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Peptide Analysis Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Peptide Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Peptide Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Peptide Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Peptide Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Peptide Analysis Services include Creative Peptides, JPT Peptide Technologies, Creative Proteomics, ProteoGenix, Smartox Biotechnology, Boston Analytical, Creative BioMart, SGS and CD ComputaBio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Peptide Analysis Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Peptide Analysis Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Peptide Analysis Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide Analysis Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Peptide Analysis Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Peptide Analysis Services revenue, projected growth trends, production technology, application and end-user industry.

Peptide Analysis Services Segment by Company

Creative Peptides

JPT Peptide Technologies

Creative Proteomics

ProteoGenix

Smartox Biotechnology

Boston Analytical

Creative BioMart

SGS

CD ComputaBio

BioPharmaSpec

Eurofins Scientific

Toray Research Center

GL Biochem

Rapid Novor

Creative Biolabs

Peptide Analysis Services Segment by Type

Biological Testing

Chemical & Physical Analyses

Surface Plasmon Resonance Imaging(SPRi)Service

Epitope Mapping Services

Peptide Characterization

Peptide Library and Array

Peptide Profiling

Peptide Analysis Services Segment by Application

Medicine

Biology

Peptide Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Peptide Analysis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Peptide Analysis Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Analysis Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Analysis Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biological Testing Major Player Table 3. Chemical & Physical Analyses Major Player Table 4. Surface Plasmon Resonance Imaging(SPRi)Service Major Player Table 5. Epitope Mapping Services Major Player Table 6. Peptide Characterization Major Player Table 7. Peptide Library and Array Major Player Table 8. Peptide Profiling Major Player Table 9. Global Peptide Analysis Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Medicine Major Player Table 11. Biology Major Player Table 12. Peptide Analysis Services Industry Trends Table 13. Peptide Analysis Services Industry Drivers Table 14. Peptide Analysis Services Industry Opportunities and Challenges Table 15. Peptide Analysis Services Industry Restraints Table 16. Global Peptide Analysis Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Peptide Analysis Services Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Peptide Analysis Services Market Share by Region (2021-2026) Table 19. Global Peptide Analysis Services Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Peptide Analysis Services Market Share by Region (2027-2032) Table 21. Global Peptide Analysis Services Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Peptide Analysis Services Revenue Market Share by Players (2021-2026) Table 23. Global Peptide Analysis Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Peptide Analysis Services Key Players Headquarters & Area Served Table 25. Global Peptide Analysis Services Players, Product Type & Application Table 26. Global Peptide Analysis Services Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Peptide Analysis Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Peptide Analysis Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Peptide Analysis Services Revenue Market Share by Type (2021-2026) Table 33. Global Peptide Analysis Services Revenue Market Share by Type (2027-2032) Table 34. Global Peptide Analysis Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Peptide Analysis Services Revenue Market Share by Application (2021-2026) Table 38. Global Peptide Analysis Services Revenue Market Share by Application (2027-2032) Table 39. Creative Peptides Company Information Table 40. Creative Peptides Business Overview Table 41. Creative Peptides Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Creative Peptides Peptide Analysis Services Product Portfolio Table 43. Creative Peptides Recent Development Table 44. JPT Peptide Technologies Company Information Table 45. JPT Peptide Technologies Business Overview Table 46. JPT Peptide Technologies Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. JPT Peptide Technologies Peptide Analysis Services Product Portfolio Table 48. JPT Peptide Technologies Recent Development Table 49. Creative Proteomics Company Information Table 50. Creative Proteomics Business Overview Table 51. Creative Proteomics Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Creative Proteomics Peptide Analysis Services Product Portfolio Table 53. Creative Proteomics Recent Development Table 54. ProteoGenix Company Information Table 55. ProteoGenix Business Overview Table 56. ProteoGenix Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ProteoGenix Peptide Analysis Services Product Portfolio Table 58. ProteoGenix Recent Development Table 59. Smartox Biotechnology Company Information Table 60. Smartox Biotechnology Business Overview Table 61. Smartox Biotechnology Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Smartox Biotechnology Peptide Analysis Services Product Portfolio Table 63. Smartox Biotechnology Recent Development Table 64. Boston Analytical Company Information Table 65. Boston Analytical Business Overview Table 66. Boston Analytical Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Boston Analytical Peptide Analysis Services Product Portfolio Table 68. Boston Analytical Recent Development Table 69. Creative BioMart Company Information Table 70. Creative BioMart Business Overview Table 71. Creative BioMart Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Creative BioMart Peptide Analysis Services Product Portfolio Table 73. Creative BioMart Recent Development Table 74. SGS Company Information Table 75. SGS Business Overview Table 76. SGS Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. SGS Peptide Analysis Services Product Portfolio Table 78. SGS Recent Development Table 79. CD ComputaBio Company Information Table 80. CD ComputaBio Business Overview Table 81. CD ComputaBio Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. CD ComputaBio Peptide Analysis Services Product Portfolio Table 83. CD ComputaBio Recent Development Table 84. BioPharmaSpec Company Information Table 85. BioPharmaSpec Business Overview Table 86. BioPharmaSpec Peptide Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. BioPharmaSpec Peptide Analysis Services Product Portfolio Table 88. BioPharmaSpec Recent Development Table 89. Eurofins Scientific Company Information Table 90. Eurofins Scientific Business Overview Table 91. Eurofins Scientific Peptide Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Eurofins Scientific Peptide Analysis Services Product Portfolio Table 93. Eurofins Scientific Recent Development Table 94. Toray Research Center Company Information Table 95. Toray Research Center Business Overview Table 96. Toray Research Center Peptide Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Toray Research Center Peptide Analysis Services Product Portfolio Table 98. Toray Research Center Recent Development Table 99. GL Biochem Company Information Table 100. GL Biochem Business Overview Table 101. GL Biochem Peptide Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. GL Biochem Peptide Analysis Services Product Portfolio Table 103. GL Biochem Recent Development Table 104. Rapid Novor Company Information Table 105. Rapid Novor Business Overview Table 106. Rapid Novor Peptide Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Rapid Novor Peptide Analysis Services Product Portfolio Table 108. Rapid Novor Recent Development Table 109. Creative Biolabs Company Information Table 110. Creative Biolabs Business Overview Table 111. Creative Biolabs Peptide Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Creative Biolabs Peptide Analysis Services Product Portfolio Table 113. Creative Biolabs Recent Development Table 114. North America Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Peptide Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 120. North America Peptide Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 121. Europe Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Peptide Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 127. Europe Peptide Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 128. China Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 129. China Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 130. China Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 131. China Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Peptide Analysis Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Peptide Analysis Services Revenue by Region (US$ Million) & (2021-2026) Table 138. Asia Peptide Analysis Services Revenue by Region (US$ Million) & (2027-2032) Table 139. SAMEA Peptide Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 140. SAMEA Peptide Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 141. SAMEA Peptide Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 142. SAMEA Peptide Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 143. SAMEA Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. SAMEA Peptide Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 145. SAMEA Peptide Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Peptide Analysis Services Image Figure 2. Global Peptide Analysis Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide Analysis Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biological Testing Image Figure 5. Chemical & Physical Analyses Image Figure 6. Surface Plasmon Resonance Imaging(SPRi)Service Image Figure 7. Epitope Mapping Services Image Figure 8. Peptide Characterization Image Figure 9. Peptide Library and Array Image Figure 10. Peptide Profiling Image Figure 11. Global Peptide Analysis Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Peptide Analysis Services Market Size Share 2021 VS 2025 VS 2032 Figure 13. Medicine Image Figure 14. Biology Image Figure 15. Global Peptide Analysis Services Market Size (US$ Million) & (2021-2032) Figure 16. Global Peptide Analysis Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Peptide Analysis Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Peptide Analysis Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peptide Analysis Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peptide Analysis Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Peptide Analysis Services Revenue Market Share by Type (2021-2032) Figure 23. Global Peptide Analysis Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Peptide Analysis Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Peptide Analysis Services Revenue Market Share by Application (2021-2032) Figure 26. North America Peptide Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Peptide Analysis Services Revenue Share by Type (2021-2032) Figure 28. North America Peptide Analysis Services Revenue Share by Application (2021-2032) Figure 29. North America Peptide Analysis Services Revenue Share by Country (2021-2032) Figure 30. United States Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Peptide Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Peptide Analysis Services Revenue Share by Type (2021-2032) Figure 35. Europe Peptide Analysis Services Revenue Share by Application (2021-2032) Figure 36. Europe Peptide Analysis Services Revenue Share by Country (2021-2032) Figure 37. Germany Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Peptide Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Peptide Analysis Services Revenue Share by Type (2021-2032) Figure 47. China Peptide Analysis Services Revenue Share by Application (2021-2032) Figure 48. Asia Peptide Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Peptide Analysis Services Revenue Share by Type (2021-2032) Figure 50. Asia Peptide Analysis Services Revenue Share by Application (2021-2032) Figure 51. Asia Peptide Analysis Services Revenue Share by Region (2021-2032) Figure 52. Japan Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Peptide Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Peptide Analysis Services Revenue Share by Type (2021-2032) Figure 60. SAMEA Peptide Analysis Services Revenue Share by Application (2021-2032) Figure 61. SAMEA Peptide Analysis Services Revenue Share by Country (2021-2032) Figure 62. Brazil Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Peptide Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Biological Testing
  • Chemical & Physical Analyses
  • Surface Plasmon Resonance Imaging(SPRi)Service
  • Epitope Mapping Services
  • Peptide Characterization
  • Peptide Library and Array
  • Peptide Profiling
Applications
  • Medicine
  • Biology
Companies covered
  • Creative Peptides
  • JPT Peptide Technologies
  • Creative Proteomics
  • ProteoGenix
  • Smartox Biotechnology
  • Boston Analytical
  • Creative BioMart
  • SGS
  • CD ComputaBio
  • BioPharmaSpec
  • Eurofins Scientific
  • Toray Research Center
  • GL Biochem
  • Rapid Novor
  • Creative Biolabs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Peptide Analysis Services Market by Type
  3. 1.2.1 Global Peptide Analysis Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biological Testing
  5. 1.2.3 Chemical & Physical Analyses
  6. 1.2.4 Surface Plasmon Resonance Imaging(SPRi)Service
  7. 1.2.5 Epitope Mapping Services
  8. 1.2.6 Peptide Characterization
  9. 1.2.7 Peptide Library and Array
  10. 1.2.8 Peptide Profiling
  11. 1.3 Peptide Analysis Services Market by Application
  12. 1.3.1 Global Peptide Analysis Services Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Medicine
  14. 1.3.3 Biology
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Peptide Analysis Services Market Dynamics
  1. 2.1 Peptide Analysis Services Industry Trends
  2. 2.2 Peptide Analysis Services Industry Drivers
  3. 2.3 Peptide Analysis Services Industry Opportunities and Challenges
  4. 2.4 Peptide Analysis Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Peptide Analysis Services Market Perspective (2021-2032)
  2. 3.2 Global Peptide Analysis Services Growth Trends by Region
  3. 3.2.1 Global Peptide Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Peptide Analysis Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Peptide Analysis Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Peptide Analysis Services Revenue by Players
  2. 4.1.1 Global Peptide Analysis Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Peptide Analysis Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Peptide Analysis Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Peptide Analysis Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Peptide Analysis Services Key Players Headquarters & Area Served
  7. 4.4 Global Peptide Analysis Services Players, Product Type & Application
  8. 4.5 Global Peptide Analysis Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Peptide Analysis Services Market CR5 and HHI
  11. 4.6.3 2025 Peptide Analysis Services Tier 1, Tier 2, and Tier 3
5 Peptide Analysis Services Market Size by Type
  1. 5.1 Global Peptide Analysis Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptide Analysis Services Revenue by Type (2021-2032)
  3. 5.3 Global Peptide Analysis Services Revenue Market Share by Type (2021-2032)
6 Peptide Analysis Services Market Size by Application
  1. 6.1 Global Peptide Analysis Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Peptide Analysis Services Revenue by Application (2021-2032)
  3. 6.3 Global Peptide Analysis Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Creative Peptides
  2. 7.1.1 Creative Peptides Company Information
  3. 7.1.2 Creative Peptides Business Overview
  4. 7.1.3 Creative Peptides Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Creative Peptides Peptide Analysis Services Product Portfolio
  6. 7.1.5 Creative Peptides Recent Developments
  7. 7.2 JPT Peptide Technologies
  8. 7.2.1 JPT Peptide Technologies Company Information
  9. 7.2.2 JPT Peptide Technologies Business Overview
  10. 7.2.3 JPT Peptide Technologies Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 JPT Peptide Technologies Peptide Analysis Services Product Portfolio
  12. 7.2.5 JPT Peptide Technologies Recent Developments
  13. 7.3 Creative Proteomics
  14. 7.3.1 Creative Proteomics Company Information
  15. 7.3.2 Creative Proteomics Business Overview
  16. 7.3.3 Creative Proteomics Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Proteomics Peptide Analysis Services Product Portfolio
  18. 7.3.5 Creative Proteomics Recent Developments
  19. 7.4 ProteoGenix
  20. 7.4.1 ProteoGenix Company Information
  21. 7.4.2 ProteoGenix Business Overview
  22. 7.4.3 ProteoGenix Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ProteoGenix Peptide Analysis Services Product Portfolio
  24. 7.4.5 ProteoGenix Recent Developments
  25. 7.5 Smartox Biotechnology
  26. 7.5.1 Smartox Biotechnology Company Information
  27. 7.5.2 Smartox Biotechnology Business Overview
  28. 7.5.3 Smartox Biotechnology Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Smartox Biotechnology Peptide Analysis Services Product Portfolio
  30. 7.5.5 Smartox Biotechnology Recent Developments
  31. 7.6 Boston Analytical
  32. 7.6.1 Boston Analytical Company Information
  33. 7.6.2 Boston Analytical Business Overview
  34. 7.6.3 Boston Analytical Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Boston Analytical Peptide Analysis Services Product Portfolio
  36. 7.6.5 Boston Analytical Recent Developments
  37. 7.7 Creative BioMart
  38. 7.7.1 Creative BioMart Company Information
  39. 7.7.2 Creative BioMart Business Overview
  40. 7.7.3 Creative BioMart Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative BioMart Peptide Analysis Services Product Portfolio
  42. 7.7.5 Creative BioMart Recent Developments
  43. 7.8 SGS
  44. 7.8.1 SGS Company Information
  45. 7.8.2 SGS Business Overview
  46. 7.8.3 SGS Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SGS Peptide Analysis Services Product Portfolio
  48. 7.8.5 SGS Recent Developments
  49. 7.9 CD ComputaBio
  50. 7.9.1 CD ComputaBio Company Information
  51. 7.9.2 CD ComputaBio Business Overview
  52. 7.9.3 CD ComputaBio Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CD ComputaBio Peptide Analysis Services Product Portfolio
  54. 7.9.5 CD ComputaBio Recent Developments
  55. 7.10 BioPharmaSpec
  56. 7.10.1 BioPharmaSpec Company Information
  57. 7.10.2 BioPharmaSpec Business Overview
  58. 7.10.3 BioPharmaSpec Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BioPharmaSpec Peptide Analysis Services Product Portfolio
  60. 7.10.5 BioPharmaSpec Recent Developments
  61. 7.11 Eurofins Scientific
  62. 7.11.1 Eurofins Scientific Company Information
  63. 7.11.2 Eurofins Scientific Business Overview
  64. 7.11.3 Eurofins Scientific Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Eurofins Scientific Peptide Analysis Services Product Portfolio
  66. 7.11.5 Eurofins Scientific Recent Developments
  67. 7.12 Toray Research Center
  68. 7.12.1 Toray Research Center Company Information
  69. 7.12.2 Toray Research Center Business Overview
  70. 7.12.3 Toray Research Center Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Toray Research Center Peptide Analysis Services Product Portfolio
  72. 7.12.5 Toray Research Center Recent Developments
  73. 7.13 GL Biochem
  74. 7.13.1 GL Biochem Company Information
  75. 7.13.2 GL Biochem Business Overview
  76. 7.13.3 GL Biochem Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GL Biochem Peptide Analysis Services Product Portfolio
  78. 7.13.5 GL Biochem Recent Developments
  79. 7.14 Rapid Novor
  80. 7.14.1 Rapid Novor Company Information
  81. 7.14.2 Rapid Novor Business Overview
  82. 7.14.3 Rapid Novor Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Rapid Novor Peptide Analysis Services Product Portfolio
  84. 7.14.5 Rapid Novor Recent Developments
  85. 7.15 Creative Biolabs
  86. 7.15.1 Creative Biolabs Company Information
  87. 7.15.2 Creative Biolabs Business Overview
  88. 7.15.3 Creative Biolabs Peptide Analysis Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Creative Biolabs Peptide Analysis Services Product Portfolio
  90. 7.15.5 Creative Biolabs Recent Developments
8 North America
  1. 8.1 North America Peptide Analysis Services Revenue (2021-2032)
  2. 8.2 North America Peptide Analysis Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Peptide Analysis Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Peptide Analysis Services Revenue by Type (2027-2032)
  5. 8.3 North America Peptide Analysis Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Peptide Analysis Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Peptide Analysis Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Peptide Analysis Services Revenue by Application (2027-2032)
  9. 8.5 North America Peptide Analysis Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Peptide Analysis Services Revenue by Country
  11. 8.6.1 North America Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Peptide Analysis Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Peptide Analysis Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Peptide Analysis Services Revenue (2021-2032)
  2. 9.2 Europe Peptide Analysis Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Peptide Analysis Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Peptide Analysis Services Revenue by Type (2027-2032)
  5. 9.3 Europe Peptide Analysis Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Peptide Analysis Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Peptide Analysis Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Peptide Analysis Services Revenue by Application (2027-2032)
  9. 9.5 Europe Peptide Analysis Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Peptide Analysis Services Revenue by Country
  11. 9.6.1 Europe Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Peptide Analysis Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Peptide Analysis Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Peptide Analysis Services Revenue (2021-2032)
  2. 10.2 China Peptide Analysis Services Revenue by Type (2021-2032)
  3. 10.2.1 China Peptide Analysis Services Revenue by Type (2021-2026)
  4. 10.2.2 China Peptide Analysis Services Revenue by Type (2027-2032)
  5. 10.3 China Peptide Analysis Services Revenue Share by Type (2021-2032)
  6. 10.4 China Peptide Analysis Services Revenue by Application (2021-2032)
  7. 10.4.1 China Peptide Analysis Services Revenue by Application (2021-2026)
  8. 10.4.2 China Peptide Analysis Services Revenue by Application (2027-2032)
  9. 10.5 China Peptide Analysis Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Peptide Analysis Services Revenue (2021-2032)
  2. 11.2 Asia Peptide Analysis Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Peptide Analysis Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Peptide Analysis Services Revenue by Type (2027-2032)
  5. 11.3 Asia Peptide Analysis Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Peptide Analysis Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Peptide Analysis Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Peptide Analysis Services Revenue by Application (2027-2032)
  9. 11.5 Asia Peptide Analysis Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Peptide Analysis Services Revenue by Country
  11. 11.6.1 Asia Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Peptide Analysis Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Peptide Analysis Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Peptide Analysis Services Revenue (2021-2032)
  2. 12.2 SAMEA Peptide Analysis Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Peptide Analysis Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Peptide Analysis Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Peptide Analysis Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Peptide Analysis Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Peptide Analysis Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Peptide Analysis Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Peptide Analysis Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Peptide Analysis Services Revenue by Country
  11. 12.6.1 SAMEA Peptide Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Peptide Analysis Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Peptide Analysis Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst